54
edits
Changes
PHAC Conflict of Interest Toolkit for Guideline Development (view source)
Revision as of 17:13, 30 March 2020
, 17:13, 30 March 2020Adding hyperlinks to resource section
=== Examples of published summaries of disclosures ===
=== Examples of published summaries of disclosures ===
* Australian Technical Advisory Group on Immunisation disclosure summary
* [https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf Australian Technical Advisory Group on Immunisation disclosure summary]
* Haute Authorité de Santé (France) examples of public disclosures of experts
* [https://www.has-sante.fr/jcms/sd_700659/fr/declaration-publique-d-interets Haute Authorité de Santé (France) examples of public disclosures of experts]
=== Examples of scales for assessing the significance of COI ===
=== Examples of scales for assessing the significance of COI ===
* American Thoracic Society method for evaluating significance of COI
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i13 American Thoracic Society method for evaluating significance of COI]
* World Health Organization criteria for assessing the severity of a conflict of interest (see p. 78)
* [https://www.who.int/publications/guidelines/handbook_2nd_ed.pdf World Health Organization criteria for assessing the severity of a conflict of interest] (see p. 78)
* USPSTF COI significance and management table
* [https://www.sciencedirect.com/science/article/pii/S0749379717303768?via%3Dihub#t0015 USPSTF COI significance and management table]
=== Examples of algorithms/process maps for COI management ===
=== Examples of algorithms/process maps for COI management ===
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure]
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure]
* CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A)
* [https://cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines.pdf CADTH pan-Canadian Oncology Drug Review COI management overview] (Appendix A)
* European Medicines Agency COI management matrix
* [https://www.ema.europa.eu/en/documents/other/policy-44-european-medicines-agency-policy-handling-competing-interests-scientific-committees_en.pdf European Medicines Agency COI management matrix]
* Institut national d’excellence en santé et en services sociaux (INESSS) diagramme de processus en matière de conflits d’intérêts (Annexe D)
* [https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/ServicesSociaux/INESSS_Cadre_elaboration_guides_pratique_servicessociaux.pdf Institut national d’excellence en santé et en services sociaux (INESSS) diagramme de processus en matière de conflits d’intérêts] (Annexe D)
* National Research Council Canada COI flowchart
* [https://nrc.canada.ca/en/corporate/values-ethics/process-flowchart-nrc-conflict-interest-post-employment-policy National Research Council Canada COI flowchart]
* National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A)
* [https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaration-of-interests-policy.pdf National Institute of Health and Care Excellence (UK) process for declaring interests] (Appendix A)
=== [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] ===
=== [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] ===